Human liver fatty aldehyde dehydrogenase: Microsomal localization, purification, and biochemical characterization

Todd L. Kelson, Julie R. Secor McVoy, William B. Rizzo

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

To better understand the genetic disorder Sjogren-Larsson syndrome which is caused by a deficiency of fatty aldehyde dehydrogenase activity, we determined the subcellular localization of the enzyme and investigated its biochemical properties. Using density gradient centrifugation, we found that fatty aldehyde dehydrogenase activity was predominantly localized in the microsomal fraction in human liver. This fatty aldehyde dehydrogenase was solubilized from human liver microsomes and purified by chromatography on columns consisting of omega-aminohexyl-agarose and 5'-AMP-Sepharose 4B. The enzyme had an apparent subunit molecular weight of 54,000, required NAD+ as cofactor, had optimal activity at pH 9.8, and was thermolabile at 47°C. Fatty aldehyde dehydrogenase had high activity towards saturated and unsaturated aliphatic aldehydes ranging from 6 to 24 carbons in length, as well as dihydrophytal, a 20-carbon branched chain aldehyde. In contrast, acetaldehyde, propionaldehyde, crotonaldehyde, glutaraldehyde, benzaldehyde, and retinaldehyde were poor substrates. The enzyme was inhibited by disulfiram, iodoacetamide, α,p-dibromoacetophenone, and p-chloromercuribenzoate. These results indicate that microsomal fatty aldehyde dehydrogenase is a distinct human aldehyde dehydrogenase isozyme that acts on a variety of medium- and long-chain aliphatic substrates.

Original languageEnglish (US)
Pages (from-to)99-110
Number of pages12
JournalBiochimica et Biophysica Acta - General Subjects
Volume1335
Issue number1-2
DOIs
StatePublished - Apr 17 1997

Fingerprint

long-chain-aldehyde dehydrogenase
Liver
Purification
Sjogren-Larsson Syndrome
2-butenal
Aldehydes
Sepharose
Enzymes
Carbon
Chloromercuribenzoates
Retinaldehyde
Iodoacetamide
Disulfiram
Aldehyde Dehydrogenase
Inborn Genetic Diseases
Acetaldehyde
Density Gradient Centrifugation
Glutaral
Liver Microsomes
NAD

Keywords

  • Aldehyde dehydrogenase
  • Fatty alcohol
  • Fatty aldehyde
  • Human liver
  • Microsomal
  • Sjogren-Larsson syndrome

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology

Cite this

Human liver fatty aldehyde dehydrogenase : Microsomal localization, purification, and biochemical characterization. / Kelson, Todd L.; Secor McVoy, Julie R.; Rizzo, William B.

In: Biochimica et Biophysica Acta - General Subjects, Vol. 1335, No. 1-2, 17.04.1997, p. 99-110.

Research output: Contribution to journalArticle

@article{0253b8230ce24246bcc98a259e366448,
title = "Human liver fatty aldehyde dehydrogenase: Microsomal localization, purification, and biochemical characterization",
abstract = "To better understand the genetic disorder Sjogren-Larsson syndrome which is caused by a deficiency of fatty aldehyde dehydrogenase activity, we determined the subcellular localization of the enzyme and investigated its biochemical properties. Using density gradient centrifugation, we found that fatty aldehyde dehydrogenase activity was predominantly localized in the microsomal fraction in human liver. This fatty aldehyde dehydrogenase was solubilized from human liver microsomes and purified by chromatography on columns consisting of omega-aminohexyl-agarose and 5'-AMP-Sepharose 4B. The enzyme had an apparent subunit molecular weight of 54,000, required NAD+ as cofactor, had optimal activity at pH 9.8, and was thermolabile at 47°C. Fatty aldehyde dehydrogenase had high activity towards saturated and unsaturated aliphatic aldehydes ranging from 6 to 24 carbons in length, as well as dihydrophytal, a 20-carbon branched chain aldehyde. In contrast, acetaldehyde, propionaldehyde, crotonaldehyde, glutaraldehyde, benzaldehyde, and retinaldehyde were poor substrates. The enzyme was inhibited by disulfiram, iodoacetamide, α,p-dibromoacetophenone, and p-chloromercuribenzoate. These results indicate that microsomal fatty aldehyde dehydrogenase is a distinct human aldehyde dehydrogenase isozyme that acts on a variety of medium- and long-chain aliphatic substrates.",
keywords = "Aldehyde dehydrogenase, Fatty alcohol, Fatty aldehyde, Human liver, Microsomal, Sjogren-Larsson syndrome",
author = "Kelson, {Todd L.} and {Secor McVoy}, {Julie R.} and Rizzo, {William B.}",
year = "1997",
month = "4",
day = "17",
doi = "10.1016/S0304-4165(96)00126-2",
language = "English (US)",
volume = "1335",
pages = "99--110",
journal = "Biochimica et Biophysica Acta - General Subjects",
issn = "0006-3002",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Human liver fatty aldehyde dehydrogenase

T2 - Microsomal localization, purification, and biochemical characterization

AU - Kelson, Todd L.

AU - Secor McVoy, Julie R.

AU - Rizzo, William B.

PY - 1997/4/17

Y1 - 1997/4/17

N2 - To better understand the genetic disorder Sjogren-Larsson syndrome which is caused by a deficiency of fatty aldehyde dehydrogenase activity, we determined the subcellular localization of the enzyme and investigated its biochemical properties. Using density gradient centrifugation, we found that fatty aldehyde dehydrogenase activity was predominantly localized in the microsomal fraction in human liver. This fatty aldehyde dehydrogenase was solubilized from human liver microsomes and purified by chromatography on columns consisting of omega-aminohexyl-agarose and 5'-AMP-Sepharose 4B. The enzyme had an apparent subunit molecular weight of 54,000, required NAD+ as cofactor, had optimal activity at pH 9.8, and was thermolabile at 47°C. Fatty aldehyde dehydrogenase had high activity towards saturated and unsaturated aliphatic aldehydes ranging from 6 to 24 carbons in length, as well as dihydrophytal, a 20-carbon branched chain aldehyde. In contrast, acetaldehyde, propionaldehyde, crotonaldehyde, glutaraldehyde, benzaldehyde, and retinaldehyde were poor substrates. The enzyme was inhibited by disulfiram, iodoacetamide, α,p-dibromoacetophenone, and p-chloromercuribenzoate. These results indicate that microsomal fatty aldehyde dehydrogenase is a distinct human aldehyde dehydrogenase isozyme that acts on a variety of medium- and long-chain aliphatic substrates.

AB - To better understand the genetic disorder Sjogren-Larsson syndrome which is caused by a deficiency of fatty aldehyde dehydrogenase activity, we determined the subcellular localization of the enzyme and investigated its biochemical properties. Using density gradient centrifugation, we found that fatty aldehyde dehydrogenase activity was predominantly localized in the microsomal fraction in human liver. This fatty aldehyde dehydrogenase was solubilized from human liver microsomes and purified by chromatography on columns consisting of omega-aminohexyl-agarose and 5'-AMP-Sepharose 4B. The enzyme had an apparent subunit molecular weight of 54,000, required NAD+ as cofactor, had optimal activity at pH 9.8, and was thermolabile at 47°C. Fatty aldehyde dehydrogenase had high activity towards saturated and unsaturated aliphatic aldehydes ranging from 6 to 24 carbons in length, as well as dihydrophytal, a 20-carbon branched chain aldehyde. In contrast, acetaldehyde, propionaldehyde, crotonaldehyde, glutaraldehyde, benzaldehyde, and retinaldehyde were poor substrates. The enzyme was inhibited by disulfiram, iodoacetamide, α,p-dibromoacetophenone, and p-chloromercuribenzoate. These results indicate that microsomal fatty aldehyde dehydrogenase is a distinct human aldehyde dehydrogenase isozyme that acts on a variety of medium- and long-chain aliphatic substrates.

KW - Aldehyde dehydrogenase

KW - Fatty alcohol

KW - Fatty aldehyde

KW - Human liver

KW - Microsomal

KW - Sjogren-Larsson syndrome

UR - http://www.scopus.com/inward/record.url?scp=0030936743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030936743&partnerID=8YFLogxK

U2 - 10.1016/S0304-4165(96)00126-2

DO - 10.1016/S0304-4165(96)00126-2

M3 - Article

C2 - 9133646

AN - SCOPUS:0030936743

VL - 1335

SP - 99

EP - 110

JO - Biochimica et Biophysica Acta - General Subjects

JF - Biochimica et Biophysica Acta - General Subjects

SN - 0006-3002

IS - 1-2

ER -